Aakash Babu

Industry analyst (healthcare)

Aakash Babu is an expert in health and pharmaceutical sector coverage, specialising in Asia-Pacific and North American regions. He looks closely at issues surrounding pandemic preparedness as well as larger disease trends and chronic conditions that currently plague health systems. He has demonstrated the ability to provide key forecasts around incoming regulatory changes and larger industry trends. His forecasting skills also tie into larger macro-economic levers. Having previously covered the pharmaceutical sector for Reuters News for more than 3 years, he also focuses on drug research and development, regulation, disease trends and approvals. He was a key member covering the covid-19 pandemic for Reuters and later for Seeking Alpha, where he was a news editor in charge of the firm’s North American coverage. He has a post-graduation in Economics and a further graduate diploma affiliated with Bloomberg from the Asian College of Journalism.